FAP-targeted [(68)Ga]BED003-PET compared with [(18)F]DOPA-PET in patients with recurrent medullary thyroid carcinoma.
Ventura D, Noto B, Backhaus P, Schindler P et al. • Frontiers in nuclear medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI:
10.3389/fnume.2026.1949036
PMC: PMC13731261